# ArriVent BioPharma, Inc.  (AVBP)

ArriVent BioPharma's $AVBP stock surges to a 52-week and all-time high, fueled by anticipation of Phase [--] FURVENT trial results and inclusion in a key biotech catalyst watchlist. The company is experiencing a significant spike in social media mentions and engagements.

### About ArriVent BioPharma, Inc.
ArriVent BioPharma, Inc. is a biopharmaceutical company focused on developing novel therapeutics.  
ArriVent BioPharma, Inc.  uses the ticker $AVBP for trading. Listed in the [Stocks](/list/stocks) category.

### Insights
- ArriVent BioPharma, Inc.  (AVBP) social dominance hit [------] which is 953% higher than it's daily average.
- ArriVent BioPharma, Inc.  (AVBP) social dominance is up 4414.29% from the previous year.
- ArriVent BioPharma, Inc.  (AVBP) Galaxy Score™ is up 112.5% from the previous [--] months.
- ArriVent BioPharma, Inc.  (AVBP) creators is up 12.64% from the previous week.
- ArriVent BioPharma, Inc.  (AVBP) engagements is up 41.3% from the previous week.
- ArriVent BioPharma, Inc.  (AVBP) mentions is up 24.57% from the previous week.
- ArriVent BioPharma, Inc.  (AVBP) posts created is up 110.88% from the previous [--] months.
- ArriVent BioPharma, Inc.  Mentions hit a 52-Week high of [---] for the day
- ArriVent BioPharma, Inc.  Mentions hit an all time of [---] for the day

### Price: $22.50
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$avbp/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$avbp/time-series/close.tsv)  
The stock price has reached a 52-week and all-time high, strongly correlated with the anticipation of upcoming clinical trial readouts, particularly the Phase [--] FURVENT trial, and its inclusion in a biotech catalyst watchlist, alongside a significant surge in social media mentions and engagements.  

24-Hour: 1.47%
7-Day: 0.27%
30-Day: 7.67%

1-Year High: $25.40 on 2025-06-16  
1-Year Low: $17 on 2025-08-12  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$avbp/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$avbp/time-series/alt_rank.tsv)  
ArriVent BioPharma, Inc.  (AVBP) is currently AltRank #1,135 based on combined combined social and market metrics
Daily Average: [-----]  
[--] Week: [---] +448  
1-Year High: [-----] on 2026-02-11  
1-Year Low: [---] on 2026-01-25  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$avbp/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$avbp/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +10  
[--] Month: [--] +17  
[--] Months: [--] +8  
[--] Year: [--] +11  
1-Year High: [--] on 2026-02-08  
1-Year Low: [--] on 2025-10-25  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$avbp/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$avbp/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [-----]  
[--] Week: [------] +41%  
[--] Month: [-------] -0.51%  
[--] Months: [-------] +128%  
[--] Year: [-------] +171%  
1-Year High: [------] on 2025-06-23  
1-Year Low: [--] on 2025-06-02  

Engagements by network (24h):
Reddit: [--]
News: [--]
YouTube: [--]
X: [-----]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$avbp/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$avbp/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [--]  
[--] Week: [---] +25%  
1-Year High: [---] on 2026-02-14  
1-Year Low: [--] on 2025-06-02  

Mentions by network (24h):
Reddit: [--]
News: [--]
YouTube: [--]
X: [---]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$avbp/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$avbp/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning ArriVent BioPharma, Inc.  (AVBP) in the last [--] hours which is down 4.20% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] +13%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-06-02  

The most influential creators that mention ArriVent BioPharma, Inc.  in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@doepke_michel](/creator/twitter/doepke_michel)     | [--]    | [------]    | [--]     | [-----]       |
| [@RiskInhibitor](/creator/twitter/RiskInhibitor)     | [--]    | [--]        | [--]     | [---]         |
| [@dagoonglove](/creator/twitter/dagoonglove)         | [--]    | [-----]     | [--]     | [---]         |
| [@WrightWhit84274](/creator/twitter/WrightWhit84274) | [--]    | [--]        | [--]    | [---]         |
| [@DudeBiotech](/creator/twitter/DudeBiotech)         | [--]    | [-----]     | [--]     | [---]         |
| [@RosaJim94865433](/creator/twitter/RosaJim94865433) | [--]    | [---]       | [--]    | [--]          |
| [@sugar_ellise](/creator/twitter/sugar_ellise)       | [--]    | [--]        | [--]    | [--]          |
| [@B71042204Ashley](/creator/twitter/B71042204Ashley) | [--]    | [--]        | [--]     | [--]          |
| [@JolieRosy96450](/creator/twitter/JolieRosy96450)   | [--]    | [--]        | [--]    | [--]          |
| [@FPopeos92355](/creator/twitter/FPopeos92355)       | [--]   | [--]        | [--]     | [--]          |

[View More](/list/creators/$avbp/100)
  
  
### Sentiment: 57%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$avbp/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$avbp/time-series/sentiment.tsv)  
Current Value: 57%  
Daily Average: 70%  
[--] Week: 100% no change  
[--] Month: 47% +7%  
[--] Months: 47% -53%  
[--] Year: 47% -53%  
1-Year High: 100% on 2025-02-19  
1-Year Low: 12% on 2025-10-10  

Most Supportive Themes:
- Biotech Stock Catalyst Watchlist: (92%) Upcoming Phase [--] and Phase [--] clinical trial readouts for various biotech stocks in Q1 2026, including $AVBP.
  
Most Critical Themes:
  
  
  
### Social Dominance: 0.015%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$avbp/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$avbp/time-series/social_dominance.tsv)  
Current Value: 0.015%  
Daily Average: 0.003%  
[--] Week: 0.0069% +0.005%  
[--] Month: 0.032% +0.031%  
[--] Months: 0.032% +0.03%  
[--] Year: 0.032% +0.031%  
1-Year High: 0.032% on 2026-02-14  
1-Year Low: 0.0001% on 2025-10-15  
  
  
### Market Dominance: 0.00105%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$avbp/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$avbp/time-series/market_dominance.tsv)  
Current Value: 0.00105%  
Daily Average: 0%  
1-Year High: 0.0012% on 2026-01-22  
1-Year Low: 0.001% on 2026-01-16  
  
  
### Market Cap: $927,179,368
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$avbp/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$avbp/time-series/market_cap.tsv)  
Current Value: $927,179,368  
Daily Average: $919,085,719  
[--] Week: $939,150,963 +1.60%  
[--] Month: $927,179,368 +2.60%  
1-Year High: $1,040,290,297 on 2026-01-22  
1-Year Low: $861,129,190 on 2026-01-16  

### Top ArriVent BioPharma, Inc.  Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"Bought more $AVBP shorting $GOSS keeping an eye on $PEPG $KYTX"  
[X Link](https://x.com/RiskInhibitor/status/2022358428241498475) [@RiskInhibitor](/creator/x/RiskInhibitor) 2026-02-13T17:13Z [--] followers, [---] engagements


"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q1 [----] 📈 $KOD Phase 2b $MDNAF Phase 2b $GOSS Phase [--] $BFRI Phase [--] $BFRI Phase [--] $KPTI Phase [--] $IOVA Phase [--] $AGIO Phase 2b $AVBP Phase [--] $ATAI Phase [--] $MLYS Phase [--] $TARA Phase [--] $CADL Phase 2a $ANRO Phase [--] $IMMP Phase [--] $PEPG Phase [--] $TBPH Phase [--] $CLDX Phase [--] $NVCR Phase [--] $VRDN Phase [--] $CMPX Phase 2/3 $ZBIO Phase [--] $IDYA Phase 2/3 $VXRT Phase 2b $OCUL Phase [--] $LSTA Phase 2b $PCSA Phase [--] $MLTX Phase [--] $OCGN Phase [--] $APGE Phase [--] $CMPS Phase [--] $MBRX Phase [--] $KOD Phase [--] $NKTR Phase 2b $ALZN Phase [--] $HELP Phase [--] $PVLA Phase [--] $ARQT"  
[X Link](https://x.com/BiopharmIQ/status/2018051066605220000) [@BiopharmIQ](/creator/x/BiopharmIQ) 2026-02-01T19:57Z 28.9K followers, 110.8K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing